Supernus Pharmaceuticals
SUPN
SUPN
93 hedge funds and large institutions have $309M invested in Supernus Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+5
Holders Change %
+5.68%
% of All Funds
2.7%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
16
Increased
36
Reduced
25
Closed
11
Calls
$2.13M
Puts
$1.1M
Net Calls
+$1.03M
Net Calls Change
-$5.53M
Top Buyers
| 1 |
MRM
1
Michael R. Murphy
|
$25.2M |
| 2 |
BC
2
Bruce & Co
Chicago,
Illinois
|
$3.48M |
| 3 |
3
Millennium Management
New York
|
$2.37M |
| 4 |
JG
4
Jefferies Group
New York
|
$4.42M |
| 5 |
PAMU
5
Pictet Asset Management (UK)
London,
United Kingdom
|
$1.98M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GC
101
Guggenheim Capital
Chicago,
Illinois
| – | -$122K | -11,187 | Closed |
|
|
FMT
102
First Mercantile Trust
Cordova,
Tennessee
| – | -$48K | -4,380 | Closed |
|
|
VFA
103
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$27K | -2,498 | Closed |
|
104
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$11K | -1,010 | Closed |
|